Given that v2 methodology is handled by InM and CDA methodology is handled by Structured Documents, having FHIR methodology handled by FHIR-I seems both consistent and appropriate. As well, methodology for all of thesse families is largely stable, so having a work group that *only* handles methodology would not involve the level of effort/engagement that would sustain a health work group (even if it made sense to try to combine methodology for all product families together - something that seems a questionnable notion given the vast differences in approach and expertise involved). If/when HL7 introduces a new product family, it might well make sense to have a separate group for managing methodology issues when the product is in the development/early adoption phases.
 |
Lloyd McKenzie (he/him/his) |
|
Management Consulting Principal Director - Healthcare Standards Email: lloyd.mckenzie@accenture.com |
CONFIDENTIALITY – This communication is confidential and for the exclusive use of its intended recipients. If you have received this communication through error, please notify the sender and delete the message without copying or disclosing.
REPRESENTATION – Unless explicitly stated otherwise, the opinions and positions expressed in this e-mail do not necessarily reflect those of my employer, my clients, nor the organizations with whom I hold governance positions